marijuana stocks news

OXIS International, Inc. (OXIS)

 

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 33   3   25   –  
Cost of Revenue 35 5 17
Gross Profit (2) (2) 8   –  
Operating Expenses
Research Development
Selling General and Administrative 1,640 547 112 101
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (1,642) (549) (104) (101)
Income from Continuing Operations
Total Other Income/Expenses Net (15,495) (407) 11 (72)
Earnings Before Interest And Taxes (17,134) (957) (94) (174)
Interest Expense 1,518 3,263 168 197
Income Before Tax (18,652) (4,220) (262) (371)
Income Tax Expense
Minority Interest 19 (1) (1) (1)
Net Income From Continuing Ops (18,633) (4,221) (263) (372)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (18,636) (4,220) (262) (371)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (18,636) (4,220) (262) (371)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

American Premium Water Corp. (OTC:HIPH) Announces Agreement with Hanlons Brewery in United Kingdom to Manufacture CBD-Infused Beer

The Company will be providing the formulations to the English Brewery to…

$VNNYF Announces Breakthrough in Oral Cannabinoid Strip

Vinergy Resources/MJ BioPharma Announces Breakthrough in Oral Cannabinoid Strip and Time Release…

Charlotte’s Web Holdings, Inc. (CWBHF) Enters Employee Health Benefits Channel in

Charlotte’s Web Enters Employee Health Benefits Channel in Partnership with SBM, LLC.…

$CARA to Webcast Presentation at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference

Cara Therapeutics to Webcast Presentation at 22nd Annual BioCentury Future Leaders in…